Atomi Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23M Sell
14,175
-2,221
-14% -$213K 0.04% 370
2025
Q4
$1.58M Buy
16,396
+1,694
+12% +$165K 0.05% 277
2025
Q3
$1.4M Buy
14,702
+3,659
+33% +$336K 0.05% 276
2025
Q2
$963K Sell
11,043
-2,076
-16% -$176K 0.04% 348
2025
Q1
$1.18M Buy
13,119
+2,611
+25% +$234K 0.05% 262
2024
Q4
$839K Sell
10,508
-1,481
-12% -$128K 0.04% 312
2024
Q3
$1.08M Buy
11,989
+3,230
+37% +$272K 0.07% 232
2024
Q2
$689K Sell
8,759
-1,410
-14% -$116K 0.05% 295
2024
Q1
$886K Buy
10,169
+753
+8% +$64.3K 0.08% 203
2023
Q4
$776K Buy
9,416
+3,777
+67% +$288K 0.11% 172
2023
Q3
$442K Buy
5,639
+70
+1% +$5.86K 0.15% 171
2023
Q2
$491K Buy
+5,569
New +$479K 0.22% 129

Other funds holding MDT

Atomi Financial Group's MDT Position: Q1 2026 in Review

Atomi Financial Group reduced its Medtronic (MDT) stake by 14% in Q1 2026, selling an estimated $213K and leaving 14,175 shares worth $1.23M. The position accounts for 0.04% of the portfolio, ranked #370.

Atomi Financial Group first reported a position in MDT in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.58M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Atomi Financial Group held 14,175 shares of Medtronic worth $1.23M as of Q1 2026.
  • Atomi Financial Group sold 2,221 Medtronic shares in Q1 2026, an estimated $213K.
  • Medtronic made up 0.04% of Atomi Financial Group's portfolio in Q1 2026, its #370 holding.
  • Atomi Financial Group first reported a position in Medtronic in Q2 2023 and has held it in 12 quarters since.
  • Atomi Financial Group's Medtronic position peaked at $1.58M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.